Self-injecting GLP-1s at home: what chronic illness TikTok gets right and wrong

What did @krissyleigh123 actually say?

The transcript here is rough. Honestly, the audio is nearly unintelligible in places, which is itself a problem when 200,000 people are watching someone demonstrate a subcutaneous injection. What we can piece together: she removes two caps from what appears to be an auto-injector pen, identifies a "sub cue needle" (subcutaneous needle), finds an injection site she calls her "file" (likely thigh), and counts while pressing the button. She mentions the injection is "finished" and signs off referencing her "pale legs."

The caption frames this as an unfiltered look at chronic illness life, positioned around the GLP-1 medication category. No drug name is stated in the transcript. No dose is mentioned. No explicit technique instruction is given in clear language. What the viewer is left with is a fragmented visual demonstration with minimal verbal guidance.

That ambiguity is the core issue here. When injection technique content reaches this scale, vague is dangerous.

Does the science back this up?

The underlying behavior, self-administering a subcutaneous GLP-1 injection using an auto-injector pen, is medically standard and well-documented. The question is whether the technique shown aligns with clinical guidelines. On that, the transcript gives us too little to be confident either way.

Auto-injector pens for GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are designed for patient self-administration. The FDA-approved prescribing information for semaglutide specifies injection into the abdomen, thigh, or upper arm, with site rotation to reduce lipohypertrophy risk. A 2020 review by Polak et al. in Diabetes Technology and Therapeutics confirmed that injection site rotation and proper subcutaneous depth are associated with better drug absorption and reduced local adverse reactions.

The thigh site she appears to use is clinically acceptable. Holding the button down for a count of several seconds, which she appears to do, is consistent with manufacturer instructions to ensure full dose delivery. These parts check out, as far as we can tell.

What did they get wrong (or right)?

Credit where it is due: using the thigh as an injection site is legitimate, and a slow button press is correct technique. The language "sub cue needle" suggests she understands this is a subcutaneous, not intramuscular, injection. That distinction matters clinically.

What is harder to defend is the lack of any clear guidance on needle disposal. Sharps safety is not optional content. The CDC estimates that 7.8 billion needles are used annually by non-professional patients in the U.S., and improper disposal is a documented public health concern. A video watched by 200,000 people showing an injection with zero mention of a sharps container is a gap, not a personal choice.

The transcript also contains what sounds like accidental pressure on the plunger before intended injection, "I want this stuff to drop everywhere," which if accurate, could represent wasted medication or a priming error. Priming a GLP-1 auto-injector incorrectly can result in dose loss. That is not a minor mistake at current medication prices.

What should you actually know?

If you are self-injecting a GLP-1 medication, the mechanics matter more than they look in a casual TikTok. First, needle cap removal order is specific to device type. Do not improvise. Always follow the instructions for your specific pen, as Ozempic, Wegovy, Mounjaro, and Zepbound pens are not identical in their cap systems.

Second, subcutaneous injection depth depends on pinching technique and body composition. A 2019 study by Kreugel et al. in Diabetes Care found that incorrect injection depth, going intramuscular instead of subcutaneous, affects insulin pharmacokinetics and likely affects GLP-1 absorption similarly.

Third, sharps disposal is a legal requirement in many U.S. states. The FDA provides a sharps disposal locator at safeneeedledisposal.org. This is not optional lifestyle content. It is a public health responsibility.

Finally, if your medication appears to have partially dispensed before injection, contact your pharmacy or prescriber. Do not attempt a partial re-dose. GLP-1 medications are dosed weekly or daily depending on the drug, and mistimed or partial doses can affect tolerability and efficacy.